103 related articles for article (PubMed ID: 10657763)
41. Histone cross-linking by transglutaminase.
Kim JH; Nam KH; Kwon OS; Kim IG; Bustin M; Choy HE; Park SC
Biochem Biophys Res Commun; 2002 May; 293(5):1453-7. PubMed ID: 12054678
[TBL] [Abstract][Full Text] [Related]
42. Transcription factor Sp1 activates involucrin promoter activity in non-epithelial cell types.
Banks EB; Crish JF; Eckert RL
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):507-12. PubMed ID: 9895295
[TBL] [Abstract][Full Text] [Related]
43. Transglutaminase cross-linking of the tau protein.
Miller ML; Johnson GV
J Neurochem; 1995 Oct; 65(4):1760-70. PubMed ID: 7561874
[TBL] [Abstract][Full Text] [Related]
44. Immunoblot analysis reveals that isopeptide antibodies do not specifically recognize the epsilon-(gamma-glutamyl)lysine bonds formed by transglutaminase activity.
Johnson GV; LeShoure R
J Neurosci Methods; 2004 Apr; 134(2):151-8. PubMed ID: 15003381
[TBL] [Abstract][Full Text] [Related]
45. Higher susceptibility to amyloid fibril formation of the recombinant ovine prion protein modified by transglutaminase.
Sorrentino A; Giosafatto CV; Sirangelo I; De Simone C; Di Pierro P; Porta R; Mariniello L
Biochim Biophys Acta; 2012 Oct; 1822(10):1509-15. PubMed ID: 22705206
[TBL] [Abstract][Full Text] [Related]
46. Alignment of fibrillin molecules in elastic microfibrils is defined by transglutaminase-derived cross-links.
Qian RQ; Glanville RW
Biochemistry; 1997 Dec; 36(50):15841-7. PubMed ID: 9398316
[TBL] [Abstract][Full Text] [Related]
47. Cross-linking sites of the human tau protein, probed by reactions with human transglutaminase.
Murthy SN; Wilson JH; Lukas TJ; Kuret J; Lorand L
J Neurochem; 1998 Dec; 71(6):2607-14. PubMed ID: 9832162
[TBL] [Abstract][Full Text] [Related]
48. Enzymatic synthesis of vasoactive intestinal peptide analogs by transglutaminase.
Esposito C; Cozzolino A; Mariniello L; Stiuso P; De Maria S; Metafora S; Ferranti P; Cartenì-Farina M
J Pept Res; 1999 Jun; 53(6):626-32. PubMed ID: 10408336
[TBL] [Abstract][Full Text] [Related]
49. Continuous enzyme-coupled assay for microbial transglutaminase activity.
Oteng-Pabi SK; Keillor JW
Anal Biochem; 2013 Oct; 441(2):169-73. PubMed ID: 23877008
[TBL] [Abstract][Full Text] [Related]
50. Sorting-out of acceptor-donor relationships in the transglutaminase-catalyzed cross-linking of crystallins by the enzyme-directed labeling of potential sites.
Lorand L; Parameswaran KN; Velasco PT
Proc Natl Acad Sci U S A; 1991 Jan; 88(1):82-3. PubMed ID: 1670900
[TBL] [Abstract][Full Text] [Related]
51. Nitric oxide inhibits cornified envelope formation in human keratinocytes by inactivating transglutaminases and activating protein 1.
Rossi A; Catani MV; Candi E; Bernassola F; Puddu P; Melino G
J Invest Dermatol; 2000 Oct; 115(4):731-9. PubMed ID: 10998152
[TBL] [Abstract][Full Text] [Related]
52. A cross-sectional study of workers with occupational exposure to petroleum derivatives.
Fenga C; Spatari G; Loreto C; Leonardi R; Germanò D
Boll Soc Ital Biol Sper; 2000; 76(9-10):67-72. PubMed ID: 11503355
[TBL] [Abstract][Full Text] [Related]
53. Two adjacent N-terminal glutamines of BM-40 (osteonectin, SPARC) act as amine acceptor sites in transglutaminaseC-catalyzed modification.
Hohenadl C; Mann K; Mayer U; Timpl R; Paulsson M; Aeschlimann D
J Biol Chem; 1995 Oct; 270(40):23415-20. PubMed ID: 7559501
[TBL] [Abstract][Full Text] [Related]
54. Cathepsin D is involved in the regulation of transglutaminase 1 and epidermal differentiation.
Egberts F; Heinrich M; Jensen JM; Winoto-Morbach S; Pfeiffer S; Wickel M; Schunck M; Steude J; Saftig P; Proksch E; Schütze S
J Cell Sci; 2004 May; 117(Pt 11):2295-307. PubMed ID: 15126630
[TBL] [Abstract][Full Text] [Related]
55. Phage display selection of efficient glutamine-donor substrate peptides for transglutaminase 2.
Keresztessy Z; Csosz E; Hársfalvi J; Csomós K; Gray J; Lightowlers RN; Lakey JH; Balajthy Z; Fésüs L
Protein Sci; 2006 Nov; 15(11):2466-80. PubMed ID: 17075129
[TBL] [Abstract][Full Text] [Related]
56. Substrate requirements for transglutaminases. Influence of the amino acid residue preceding the amine donor lysine in a native protein.
Grootjans JJ; Groenen PJ; de Jong WW
J Biol Chem; 1995 Sep; 270(39):22855-8. PubMed ID: 7559419
[TBL] [Abstract][Full Text] [Related]
57. Interactions of recombinant mouse erythrocyte transglutaminase with membrane skeletal proteins.
Gutierrez E; Sung LA
J Membr Biol; 2007 Oct; 219(1-3):93-104. PubMed ID: 17763875
[TBL] [Abstract][Full Text] [Related]
58. The intermediate filament protein, vimentin, in the lens is a target for cross-linking by transglutaminase.
Clément S; Velasco PT; Murthy SN; Wilson JH; Lukas TJ; Goldman RD; Lorand L
J Biol Chem; 1998 Mar; 273(13):7604-9. PubMed ID: 9516464
[TBL] [Abstract][Full Text] [Related]
59. Novel transglutaminase inhibitors reduce the cornified cell envelope formation.
Kim SY; Park WM; Jung SW; Lee J
Biochem Biophys Res Commun; 1997 Apr; 233(1):39-44. PubMed ID: 9144392
[TBL] [Abstract][Full Text] [Related]
60. Identification of glutamine and lysine residues in Alzheimer amyloid beta A4 peptide responsible for transglutaminase-catalysed homopolymerization and cross-linking to alpha 2M receptor.
Rasmussen LK; Sørensen ES; Petersen TE; Gliemann J; Jensen PH
FEBS Lett; 1994 Jan; 338(2):161-6. PubMed ID: 7905838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
